| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827987 | European Urology Focus | 2017 | 9 Pages |
Abstract
Use of statins after prostate cancer diagnosis was associated with a decreased risk of prostate cancer death. The risk decrease was dose-dependent and observed especially among patients treated with hormone therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Teemu J. Murtola, Antti I. Peltomaa, Kirsi Talala, Liisa Määttänen, Kimmo Taari, Teuvo L.J. Tammela, Anssi Auvinen,